Member Info for CHELSEA7

+ Russia, lol

https://www.pharmaceutical-technology.com/special-focus/covid-19/globaldata-epidemiologist-report-global-covid-19-cases-pass-3-5-million-fatalities-approach-250000-sharp-rise-of-cases-in-russia/?utm_source=Push%20Notification&utm_medium=website&utm_campaign=industry_alerts&utm_content=standard

Funny enough mivoce I felt the same after reading your post, lol.

good to see you posting over here.

Good to see a sunrise again. Hope everyone is bearing up well.

Strange doings yesterday were"nt they?? I didn"t comment on it really as it seemed there must be quite a hefty delayed sell to come at 8p odd, but just seen the 600k trade at 8.30 which makes little sense.

Anyway, it is a new day, sure a delayed sell will pop up if and when ready.

Been enjoying quite a few posts of late, good luck to all.

133 Trades

Hi Ivy, this update you have mentione4d a few times. Don"t you think Scancell will be a better poition re up n update once they know exactly what if any funding they will get towards COVID 19??

Probably a 1m sell at 8p holding us up. Just mo.

GN All

Taking 220k+ at 8.17

Interesting trades

13:30:13 8.285 25,000 2,071 O
13:17:29 8.2959 60,174 4,992 O
13:14:36 8.30 50,000 4,150

Trade at 8.23 is a sell, not a buy

11:20:59 8.30 60,000 4,980 O
11:17:24 8.30 17,712 1,470 O
11:10:26 8.30 10,156 842.95 O
11:08:05 8.30 120,481 10,000 O
11:04:02 8.30 7,132 591.96 O
11:03:29 8.30 40,000 3,320 O
11:01:31 8.30 250,000 20.75k O
10:50:54 8.30 9,230 766.09 O
10:49:41 8.30 2,868 238.04 O
10:44:38 8.30 35,000 2,905 O
10:40:31 8.30 60,168 4,994

At 8.30 too, half a million buys at 8.30!!!

11:04:02 8.30 7,132 591.96 O
11:03:29 8.30 40,000 3,320 O
11:01:31 8.30 250,000 20.75k O
10:50:54 8.30 9,230 766.09 O
10:49:41 8.30 2,868 238.04 O
10:44:38 8.30 35,000 2,905 O

At 8.30............sixth time 8.30 Paid

Heading North!!!

8.30 Paid 60k and 30k and looks like going bck up.

Apologies if in agreeing with the basis of your post I used milestone payments as a given if it was something you had said.

Somebody else does that and if it wasn"t milestone payments you were getting at, it was the basis for any deal I approved of, just felt you were more than considering milestone payments in your post anyway.

As global efforts to tackle the coronavirus (COVID-19) pandemic intensify, so the spotlight has finally shifted to focus on the potential of small pharma players.

According to Ivan Sedgwick, a director at corporate finance firm LGB & Co, the poor share price performance of major healthcare names has demoralised investors, forcing them in their quest for value into unfamiliar territory such as AIM.

“Investors have moved from a focus on balance sheet and funding risk and are back looking at the upside potential that some of these companies exhibit,” Sedgwick noted.

Among his top picks are Scancell Holdings PLC (LON:SCLP), part of a coronavirus vaccine programme; university spin-out investor Frontier IP Group PLC (LON:FIPP); and Open Orphan PLC (LON:ORPH), which is testing an antiviral.

https://www.proactiveinvestors.co.uk/companies/news/918643/small-cap-movers-coronavirus-crisis-shines-a-light-on-small-cap-pharma-918643.html

Share Prophets on Friday......................

This is my day of peak recordings - 7 hours of interviews and bearcast underway. I kid you not. apart from bearcast it is all great material for the ************* shares show on May 9. I have just done the Jim Mellon recording which should knock your socks off. Poor man, he is trapped in lockdown in the Isle of Man but seems to be bearing up well. Anyhow, buy your ticket HERE. In this podcast I look at Eurasia Mining (EUA), Scancell (SCLP), 13 Energy (I3E), Arden Partners (ARDN), Petra Diamonds (PDL) and Intu (INTU).

From S

Thanks for that Cars, no I hadn"t seen that before. Can only be good.

Some really good posts today, Lindys CV and partners will open doors, and I tend to agree with Dalestar on this one. Milestone payments, ""small retainer"" and what I don"t think many of us know is what is considered ""small"" for such an ambitious project.

Lets see what the week brings, I rather fancy an update from Scancell on this one, just reading the original RNS we know we have been working on this for time, from Q1 to Autumn 2020 tells us how far we have come, and I don"t think it is unrealistic to think talks have been going on with interested parties for some time too. Maybe for once our timing is perfet and hoping that in itself is the lucky break we have been so desperate for for so long.

Heres to a great week guys, got a very good feeling over this. Catch yer tomorrow. GN

I sure would too!!!

Shareguard I tend to agree with you, happy to let Scancell decide on that one, there are numerous ways of seeking recompense.

Thinking on that one Ray, this could certainly open up into a fourth platform, for other known diseases, as David Evans spoke about around 2013, certainly our flirtations with Karolinska on rheumo arthroid studies and however number of fevers that turn up from time to time. Don"t you think that is important enough to Patent??

All rather decent timing for any Avidamab commercial activity.

Originally with the SCIB1 trial recruiting i felt a May raising would be on the cards, not October as I originally felt, but this sequence of events could ssee us through summer and put us in a far higher position to get a good raising away. £8/10m with Moditope will be needed.

I